LATEST

• REGULATORY MHLW Opens Applications for Innovation Fund’s Ecosystem Program
  October 7, 2026

• BUSINESS 1 in 4 Epilepsy Patients Dissatisfied with Current Drugs: Survey
  October 7, 2026

• BUSINESS Fujifilm Adds Linker-Payload Capacity to Build One-Stop ADC CDMO Service
  October 7, 2026

• BUSINESS Asahi Kasei Therapeutics Reports Potential Data Breach Affecting 560,000
  October 7, 2026

• BUSINESS Toho Files Objection to Court Block on Takeover Defense Move
  October 7, 2026

• BUSINESS Keytruda Marks 3 Years at No. 1 in September: Encise
  October 7, 2026

• BUSINESS Shionogi to Offload Allergy Drug Actair to Ceolia
  October 7, 2026

• ORGANIZATION PhRMA Taps Jonathan Kushner as New Japan Representative
  October 6, 2026

• BUSINESS LinDo Sets Sights on More Pediatric Deals as It Builds Drug-Loss Portfolio
  October 6, 2026

• BUSINESS Shionogi to Buy IntraBio for US$2 Billion, Gains Rare Disease Drug
  October 6, 2026

• COMMENTARY Japan Moves to Break Plasma Product Capacity Crunch with Factory Aid
  October 6, 2026

• ACADEMIA Bosutinib Set to Enter PIII for ALS in Japan in 2027
  October 6, 2026

• BUSINESS Fujifilm AI Finds Potent New Inhibitors from Known Compound
  October 6, 2026

• BUSINESS Boehringer’s Survodutide Makes Mark in Japan PIII Obesity Trial
  October 6, 2026

• BUSINESS Kyowa Finds Nitrosamines in 2 Antidepressants; No Recall Planned
  October 6, 2026

• REGULATORY Takaichi Puts Health Security on Crisis Management Investment Agenda
  October 6, 2026

• BUSINESS Nippon Zoki Bags Japan Rights to Taiwan Firm’s Knee Osteoarthritis Drug
  October 6, 2026

• BUSINESS AstraZeneca, Academic Society Join Hands on Obesity Care in Japan
  October 6, 2026

• BUSINESS Daiichi Sankyo to Take Sole Charge of Emgality Information Activities
  October 6, 2026

• BUSINESS Shionogi CVC Invests in Celaid Therapeutics
  October 6, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »